Literature DB >> 1500204

In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans.

K Truelsen1, T Young, T R Kozel.   

Abstract

Tissues from mice infected with Cryptococcus neoformans were examined by immunofluorescence to determine the extent of deposition of complement component C3 on encapsulated cryptococci. The relative percentages of cryptococci in each tissue having readily visible C3 were greatest for liver and lung tissues, with the kidney tissue having the next highest percentage and the spleen having the lowest percentage. Binding of C3 fragments to cryptococci in brain tissue was essentially absent.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1500204      PMCID： PMC257415          DOI： 10.1128/iai.60.9.3937-3939.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.

Authors:  M A Wilson; T R Kozel
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Complement depletion in cryptococcal sepsis.

Authors:  A M Macher; J E Bennett; J E Gadek; M M Frank
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  Immunofluorescence studies of reactions at the Cryptococcal capsule.

Authors:  M B Goren; J Warren
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

5.  The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay.

Authors:  B C Dujardin; P C Driedijk; A F Roijers; T A Out
Journal:  J Immunol Methods       Date:  1985-06-25       Impact factor: 2.303

6.  Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease.

Authors:  H H Gadebusch; A G Johnson
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

7.  Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.

Authors:  C Spiropulu; R A Eppard; E Otteson; T R Kozel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.

Authors:  T R Kozel; G S Pfrommer; A S Guerlain; B A Highison; G J Highison
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis.

Authors:  J C Rhodes
Journal:  Sabouraudia       Date:  1985-06

10.  Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.

Authors:  T R Kozel; M A Wilson; J W Murphy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441
  10 in total
  13 in total

1.  Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.

Authors:  S M Levitz; E A North; Y Jiang; S H Nong; H Kornfeld; T S Harrison
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.

Authors:  Kileen L Mershon-Shier; Alex Vasuthasawat; Kazue Takahashi; Sherie L Morrison; David O Beenhouwer
Journal:  Mol Immunol       Date:  2011-07-01       Impact factor: 4.407

Review 3.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

4.  Intravascular clearance of disseminating Cryptococcus neoformans in the brain can be improved by enhancing neutrophil recruitment in mice.

Authors:  Donglei Sun; Mingshun Zhang; Gongguan Liu; Hui Wu; Chang Li; Hong Zhou; Xiquan Zhang; Meiqing Shi
Journal:  Eur J Immunol       Date:  2016-06-08       Impact factor: 5.532

Review 5.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 6.  Activation of the complement system by pathogenic fungi.

Authors:  T R Kozel
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

7.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.

Authors:  S Mukherjee; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies.

Authors:  Oscar Zaragoza; Arturo Casadevall
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.

Authors:  Donglei Sun; Mingshun Zhang; Gongguan Liu; Hui Wu; Xiaoping Zhu; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.